At close: 4:08:20 PM GMT+8
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | -1.01 | -1.26 |
| Low Estimate | 0 | 0 | -1.01 | -1.26 |
| High Estimate | 0 | 0 | -1.01 | -1.26 |
| Year Ago EPS | -- | -- | -1.05 | -1.01 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 588.5k | 745.13k |
| Low Estimate | -- | -- | 588.5k | 745.13k |
| High Estimate | -- | -- | 588.5k | 745.13k |
| Year Ago Sales | -- | -- | 386k | 588.5k |
| Sales Growth (year/est) | -- | -- | 52.46% | 26.62% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -1.01 | -1.26 |
| 7 Days Ago | 0 | 0 | -1.01 | -1.26 |
| 30 Days Ago | 0 | 0 | -1.01 | -1.26 |
| 60 Days Ago | 0 | 0 | -1.01 | -1.26 |
| 90 Days Ago | 0 | 0 | -1.01 | -1.26 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 1541.HK | -- | -- | 3.81% | -24.75% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Related Tickers
9969.HK InnoCare Pharma Limited
6.150
-0.32%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
179.400
-4.37%
688266.SS Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
64.64
-4.36%
2105.HK Laekna, Inc.
10.840
-8.75%
688428.SS InnoCare Pharma Limited
13.39
-1.76%
2487.HK Cutia Therapeutics
7.010
-1.27%
3681.HK SinoMab BioScience Limited
1.050
-5.41%
9966.HK Alphamab Oncology
3.410
-7.59%
2162.HK Keymed Biosciences Inc.
34.550
-8.84%
6628.HK Transcenta Holding Limited
0.610
0.00%